Rash, Systemic Treatments, Tele-assessment
Conditions
Brief summary
This study is being done to find out if video consultations (telemedicine) can be used to safely and effectively assess and manage skin problems caused by cancer treatments. Instead of always coming to the hospital for a face-to-face appointment, the patient may be able to use thier smartphone or computer to show your skin to a nurse or doctor over a secure video call. the researchers want to see if this is as good as a regular clinic visit, and whether patients and staff are happy with this new way of working.
Interventions
OTHERtelem healthassessment
SOC is face to face assessment-this study aims to use telemedecine toassess Treatment related skin disorders
Sponsors
Sligo General Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
Participants must meet all of the following criteria: * Adult oncology or haematology patients currently receiving systemic anti-cancer therapy (SACT). * New-onset dermatologic toxicity consistent with a recognised adverse effect of the administered SACT. * Skin toxicity severity graded ≤ Grade 2 in accordance with UKONS assessment criteria. * Clinically stable condition not requiring urgent in-person evaluation. * Access to, and ability to use, a smartphone or computer with adequate internet connectivity to participate in telemedicine consultations.
Exclusion criteria
Participants will be excluded if any of the following criteria apply: * Skin toxicity graded ≥ Grade 3 according to UKONS assessment criteria. * Clinical status requiring urgent or immediate face-to-face medical assessment. * Dermatologic toxicity that is atypical, unexpected, or not consistent with known SACT-related adverse effects. * Inability to access or effectively use the required telemedicine technology.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| time to clinical resolution | 6 weeks | Number of days from first AHOS contact to documented resolution (Grade 0-1). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Escalation in person review | 6 weeks | Proportion of telemedicine patients requiring: * Conversion to face-to-face review * Emergency department attendance * Hospital admission |
| treatment modification reat | 6 weeks | Proportion of telemedicine patients requiring: * Conversion to face-to-face review * Emergency department attendance * Hospital admission |
| unscheduled acute contact | 6 weeks | Number of unplanned re-contacts with AHOS |
| Patient-Reported Endpoints -Quality of Life (QoL) and patient satisfaction | 6 weeks | Instrument: QLQ administered: * Post initial assessment * At resolution or week 6 |
Countries
Ireland
Outcome results
None listed